Abstract
The report provides a critical examination of the use of octreotide at a dosage of 20 mu g/kg/h in the treatment of congenital chylothorax. The case analysis recounts a recent application of high-dosage octreotide in the treatment of a neonatal patient who failed to respond to a lower dosage of octreotide. In this case, the patient responded effectively to octreotide at 20 mu g/kg/h and was subsequently discharged without any side effects. This case is compared with similar cases published in recent literature to advance the clinical analysis of a potential application of high-dose octreotide in the treatment of congenital chylothorax when lower dosages fail to produce results.